339 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B Downtrend
Article Searches
Chemed (CHE) Q4 Earnings Beat Estimates, Gross Margin Falls http://www.zacks.com/stock/news/356727/chemed-che-q4-earnings-beat-estimates-gross-margin-falls?cid=CS-ZC-FT-356727 Feb 25, 2019 - Chemed's (CHE) Q4 revenues grow across key segments.
Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2018 http://www.gurufocus.com/news/821302/abbott-laboratories-abt-files-10k-for-the-fiscal-year-ended-on-december-31-2018 Feb 22, 2019 - Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: ABT, release date:Feb 22, 2019
Quest Diagnostics Grows on Innovation Amid Reimbursement Woe http://www.zacks.com/stock/news/356629/quest-diagnostics-grows-on-innovation-amid-reimbursement-woe?cid=CS-ZC-FT-356629 Feb 22, 2019 - Quest Diagnostics' (DGX) progress in prescription drug monitoring, QuantiFERON and non-invasive prenatal screening are part of its recent major developments.
Here's Why Investors Should Hold DaVita (DVA) Stock Now http://www.zacks.com/stock/news/356474/heres-why-investors-should-hold-davita-dva-stock-now?cid=CS-ZC-FT-356474 Feb 22, 2019 - DaVita (DVA) steadily expands in international markets. Moreover, the company has witnessed Dialysis services in the United States lately.
NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall http://www.zacks.com/stock/news/356399/nuvasive-nuva-q4-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-356399 Feb 22, 2019 - NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.
CVS Health's (CVS) Q4 Earnings Top Estimates, Margins Up http://www.zacks.com/stock/news/355792/cvs-healths-cvs-q4-earnings-top-estimates-margins-up?cid=CS-ZC-FT-355792 Feb 20, 2019 - CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition holds immense promise.
Intuitive Surgical Gets FDA Nod for Ion Endoluminal System http://www.zacks.com/stock/news/355677/intuitive-surgical-gets-fda-nod-for-ion-endoluminal-system?cid=CS-ZC-FT-355677 Feb 20, 2019 - The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Here's Why Investors Should Buy Surmodics (SRDX) Stock Now http://www.zacks.com/stock/news/355434/heres-why-investors-should-buy-surmodics-srdx-stock-now?cid=CS-ZC-FT-355434 Feb 19, 2019 - Surmodics' (SRDX) solid efforts to improve its research and development stature are likely to prove beneficial in the quarters ahead.
Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B http://www.zacks.com/stock/news/354868/johnson-johnson-jnj-to-acquire-auris-health-for-%2434b?cid=CS-ZC-FT-354868 Feb 14, 2019 - Johnson & Johnson (JNJ) entered into a definitive agreement to acquire Auris Health, Inc., a developer of robotic technologies focused on lung cancer, for approximately $3.4 billion in cash.
Boston Scientific Benefits From New Buyouts & Product Launch http://www.zacks.com/stock/news/354133/boston-scientific-benefits-from-new-buyouts-product-launch?cid=CS-ZC-FT-354133 Feb 13, 2019 - Boston Scientific's (BSX) closure of Millipede acquisition and its buyout agreement with BTG plc are major developments for the company.

Pages: 1234567891011...34

<<<Page 6>